Plant-based production of two chimeric monoclonal IgG antibodies directed against immunodominant epitopes of Vibrio cholerae lipopolysaccharide
- PMID: 25865265
- PMCID: PMC4458452
- DOI: 10.1016/j.jim.2015.04.001
Plant-based production of two chimeric monoclonal IgG antibodies directed against immunodominant epitopes of Vibrio cholerae lipopolysaccharide
Abstract
We have produced and characterized two chimeric human IgG1 monoclonal antibodies that bind different immunodominant epitopes on Vibrio cholerae lipopolysaccharide (LPS). MAb 2D6 IgG1 recognizes Ogawa O-polysaccharide antigen, while mAb ZAC-3 IgG1 recognizes core/lipid A moiety of Ogawa and Inaba LPS. Both antibodies were expressed using a Nicotiana benthamiana-based rapid antibody-manufacturing platform (RAMP) and evaluated in vitro for activities associated with immunity to V. cholerae, including vibriocidal activity, bacterial agglutination and motility arrest.
Keywords: Antibodies; Cholera; Plant expression; Vaccine.
Copyright © 2015 Elsevier B.V. All rights reserved.
Figures


Similar articles
-
On the antigenic determinants of the lipopolysaccharides of Vibrio cholerae O:1, serotypes Ogawa and Inaba.J Biol Chem. 1998 Jan 30;273(5):2777-83. doi: 10.1074/jbc.273.5.2777. J Biol Chem. 1998. PMID: 9446585
-
Immunochemical characterization of an Ogawa-Inaba common antigenic determinant of Vibrio cholerae O1.Microbiology (Reading). 1999 Sep;145 ( Pt 9):2477-2484. doi: 10.1099/00221287-145-9-2477. Microbiology (Reading). 1999. PMID: 10517600
-
Impact of Immunoglobulin Isotype and Epitope on the Functional Properties of Vibrio cholerae O-Specific Polysaccharide-Specific Monoclonal Antibodies.mBio. 2021 Apr 20;12(2):e03679-20. doi: 10.1128/mBio.03679-20. mBio. 2021. PMID: 33879588 Free PMC article.
-
[Aspects of Vibrio cholerae lipopolysaccharide].Zh Mikrobiol Epidemiol Immunobiol. 2002 Mar-Apr;(2):102-7. Zh Mikrobiol Epidemiol Immunobiol. 2002. PMID: 12043141 Review. Russian.
-
RNA modulating specific and nonspecific immune responses.Ann N Y Acad Sci. 1979;332:187-95. doi: 10.1111/j.1749-6632.1979.tb47112.x. Ann N Y Acad Sci. 1979. PMID: 93861 Review. No abstract available.
Cited by
-
A monoclonal antibody that targets the conserved core/lipid A region of lipopolysaccharide affects motility and reduces intestinal colonization of both classical and El Tor Vibrio cholerae biotypes.Vaccine. 2016 Nov 21;34(48):5833-5836. doi: 10.1016/j.vaccine.2016.10.023. Epub 2016 Oct 20. Vaccine. 2016. PMID: 27773473 Free PMC article.
-
Inhibition of invasive salmonella by orally administered IgA and IgG monoclonal antibodies.PLoS Negl Trop Dis. 2020 Mar 23;14(3):e0007803. doi: 10.1371/journal.pntd.0007803. eCollection 2020 Mar. PLoS Negl Trop Dis. 2020. PMID: 32203503 Free PMC article.
-
Passive Immunity to Vibrio cholerae O1 Afforded by a Human Monoclonal IgA1 Antibody Expressed in Milk.Pathog Immun. 2020 May 8;5(1):89-116. doi: 10.20411/pai.v5i1.370. eCollection 2020. Pathog Immun. 2020. PMID: 34136728 Free PMC article.
-
Multiple Modes of Action of a Monoclonal Antibody against Multidrug-Resistant Escherichia coli Sequence Type 131-H30.Antimicrob Agents Chemother. 2017 Oct 24;61(11):e01428-17. doi: 10.1128/AAC.01428-17. Print 2017 Nov. Antimicrob Agents Chemother. 2017. PMID: 28874372 Free PMC article.
-
Vibrio cholerae O1 secretes an extracellular matrix in response to antibody-mediated agglutination.PLoS One. 2018 Jan 2;13(1):e0190026. doi: 10.1371/journal.pone.0190026. eCollection 2018. PLoS One. 2018. PMID: 29293563 Free PMC article.
References
-
- Alam MM, Bufano MK, Xu P, Kalsy A, Yu Y, Freeman YW, Sultana T, Rashu MR, Desai I, Eckhoff G, Leung DT, Charles RC, LaRocque RC, Harris JB, Clements JD, Calderwood SB, Qadri F, Vann WF, Kovac P, Ryan ET. Evaluation in mice of a conjugate vaccine for cholera made from Vibrio cholerae O1 (Ogawa) O-specific polysaccharide. PLoS Negl Trop Dis. 2014;8:e2683. - PMC - PubMed
-
- Apter FM, Michetti P, Winner LSd, Mack JA, Mekalanos JJ, Neutra MR. Analysis of the roles of antilipopolysaccharide and anti-cholera toxin immunoglobulin A (IgA) antibodies in protection against Vibrio cholerae and cholera toxin by use of monoclonal IgA antibodies in vivo. Infect Immun. 1993;61:5279–85. - PMC - PubMed
-
- Charles RC, Hilaire IJ, Mayo-Smith LM, Teng JE, Jerome JG, Franke MF, Saha A, Yu Y, Kovac P, Calderwood SB, Ryan ET, LaRocque RC, Almazor CP, Qadri F, Ivers LC, Harris JB. Immunogenicity of a killed bivalent (O1 and O139) whole cell oral cholera vaccine, Shanchol, in Haiti. PLoS Negl Trop Dis. 2014;8:e2828. - PMC - PubMed
-
- Chatterjee SN, Chaudhuri K. Lipopolysaccharides of Vibrio cholerae. I. Physical and chemical characterization. Biochim Biophys Acta. 2003;1639:65–79. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources